申请人:AFECTA PHARMACEUTICALS, INC.
公开号:US20200039922A1
公开(公告)日:2020-02-06
Compounds, pharmaceutically acceptable salts, and pharmaceutical compositions thereof are disclosed that are useful for inhibition of the biological activity of HMGB1, as well as methods of treatment for diseases involving the inflammation activity or cytokine activity of HMGB1.